3Suppliers
18Customers
3Debt Items
4Related Chains

Source-Backed Evidence Depth

Rockwell Medical, Inc. (RMTI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships
4Distinct source URLs
17High confidence
0.804Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Rockwell Medical, Inc. Suppliers

TickerNameConfidenceEvidence
DAVITA DAVITA 90% under which the Company supplies DaVita with certain dialysis concentrates.
FRESENIUS FRESENIUS 90% under which the Company supplies DaVita with certain dialysis concentrates.
XRTX XORTX Therapeutics Inc. 72% Reciprocal relationship from XRTX graph: Reciprocal relationship from RMTI graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from RMTI graph: Reciprocal relationship from XRTX g…

Rockwell Medical, Inc. Customers

TickerNameConfidenceEvidence
DAVITA DAVITA 92% Rockwell currently serves 294 customers, highlighted by all five of the leading dialysis providers in the United States, including Fresenius and DaVita.
FRESENIUS FRESENIUS 92% Rockwell currently serves 294 customers, highlighted by all five of the leading dialysis providers in the United States, including Fresenius and DaVita.
FRESENIUS-MEDICAL-CARE-NORTH-AMERICA FRESENIUS-MEDICAL-CARE-NORTH-AMERICA 92% For the three months ended March 31, 2026, revenues from sales to two customers, Fresenius Medical Care North America ("Fresenius") and Nipro Medical Corporation, a subsidiary of Nipro Corporation Ja…
INNOVATIVE-RENAL-CARE INNOVATIVE-RENAL-CARE 92% In July 2025, Rockwell Medical signed a multi-year product purchase agreement with Innovative Renal Care, one of the largest dialysis service providers in the United States.
NIPRO-MEDICAL-CORPORATION NIPRO-MEDICAL-CORPORATION 92% For the three months ended March 31, 2026, revenues from sales to two customers, Fresenius Medical Care North America ("Fresenius") and Nipro Medical Corporation, a subsidiary of Nipro Corporation Ja…
EVOQUA-WATER-TECHNOLOGIES EVOQUA-WATER-TECHNOLOGIES 90% The final Evoqua payment was made in April 2026.
ONE-OF-THE-LARGEST-DIALYSIS-PROVIDERS-IN-THE-UNI ONE-OF-THE-LARGEST-DIALYSIS-PROVIDERS-IN-THE-UNI 90% In December 2025, we extended our Amended and Restated Products Purchase Agreement (the "Amended Agreement") dated September 18, 2023 with one of the largest dialysis providers in the United States t…
EVOQUA-WATER-TECHNOLOGIES-LLC EVOQUA-WATER-TECHNOLOGIES-LLC 85% mpact this ASU will have on the consolidated financial statements and footnote disclosures. Note 4. Intangible Assets and Deferred Consideration Intangible Assets Our customer relationship intangible…
DROGSAN-PHARMACEUTICALS DROGSAN-PHARMACEUTICALS 80% Three months ended March 31, 2025 includes $0.3 million of deferred revenue related to the distribution and license agreements with Sun Pharmaceuticals Industries Ltd., Jeil Pharmaceutical Co., Ltd. …
JEIL-PHARMACEUTICAL-CO-LTD JEIL-PHARMACEUTICAL-CO-LTD 80% Three months ended March 31, 2025 includes $0.3 million of deferred revenue related to the distribution and license agreements with Sun Pharmaceuticals Industries Ltd., Jeil Pharmaceutical Co., Ltd. …
SUN-PHARMACEUTICALS-INDUSTRIES-LTD SUN-PHARMACEUTICALS-INDUSTRIES-LTD 80% Three months ended March 31, 2025 includes $0.3 million of deferred revenue related to the distribution and license agreements with Sun Pharmaceuticals Industries Ltd., Jeil Pharmaceutical Co., Ltd. …
ABOUT-ROCKWELL-MEDICAL-ROCKWELL-MEDICAL-INC ABOUT-ROCKWELL-MEDICAL-ROCKWELL-MEDICAL-INC 62% sures, including net loss and other GAAP results. About Rockwell Medical Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a p…
ARMISTICE-CAPITAL-MASTER-FUND-LTD ARMISTICE-CAPITAL-MASTER-FUND-LTD 62% els, in order to evaluate operating results and performance in deciding how to allocate resources. The measure of segment assets is reported on the condensed consolidated balance sheets as total asse…
CHARAK-LLC CHARAK-LLC 62% ed over the vesting period. The vesting periods range from one to three years . As of December 31, 2025, the unrecognized stock-based compensation expense was $ 0.7 million, which is expected to be r…
L-E-K-CONSULTING-LLC L-E-K-CONSULTING-LLC 62% the largest suppliers of acid and dry bicarbonate concentrates for dialysis patients in the United States. Based on an independent research report that the Company commissioned from L.E.K. Consulting…
ROCKWELL-MEDICAL-INDIA-PRIVATE-LIMITED ROCKWELL-MEDICAL-INDIA-PRIVATE-LIMITED 62% States and internationally utilizing its own delivery trucks and third-party carriers. Rockwell was incorporated in the state of Michigan in 1996 and re-domiciled to the state of Delaware in 2019. Ou…
ROCKWELL-TRANSPORTATION-INC ROCKWELL-TRANSPORTATION-INC 62% States and internationally utilizing its own delivery trucks and third-party carriers. Rockwell was incorporated in the state of Michigan in 1996 and re-domiciled to the state of Delaware in 2019. Ou…
SUN-PHARMACEUTICAL-INDUSTRIES-LTD SUN-PHARMACEUTICAL-INDUSTRIES-LTD 62% tions The following table summarizes our operating results for the periods presented below (dollars in thousands): For the Year Ended December 31, 2025 % of Revenue 2024 % of Revenue % Change Net Sal…

Rockwell Medical, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RMTI-DEBT-12238 Xbrl Convertible 90% xbrl convertible detail from xbrl 2014-12-31.
RMTI-DEBT Debt stack $9.0M 90% Market cache reports total debt of $9.0M.
RMTI-DEBT-12237 Warrants outstanding: 2770781 90% xbrl warrant detail from xbrl 2024-12-31.

Rockwell Medical, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Rockwell Medical, Inc..

Rockwell Medical, Inc. Ownership

HolderNameConfidenceEvidence
RMTI-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 44 tracked holders.

Rockwell Medical, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DAVITA DAVITA 63.48 1 ['receiving']
DFTX Definium Therapeutics, Inc. 50.00 2
CROS CROS 50.00 2
XRTX XORTX Therapeutics Inc. 36.29 1 ['supplier']
🔐
RMTI
Unlock RMTI Supply Chain Data
Verified relationships include:
DAVITADAVITASupplier90%
FRESENIUSFRESENIUSSupplier90%
DAVITADAVITACustomer92%
FRESENIUSFRESENIUSCustomer92%
+21 more relationships locked
Subscribe — View plans →